Nurix Therapeutics (NRIX) Earnings Date & Reports

A.I. Advisor

published Earnings

NRIX is expected to report earnings to fall 7.48% to -65 cents per share on October 10

Nurix Therapeutics NRIX Stock Earnings Reports

Q3'24

Est.

$-0.66

Q2'24

Missed

by $0.08

Q1'24

Beat

by $0.02

Q4'23

Missed

by $0.27

Q3'23

Beat

by $0.16

The last earnings report on July 11 showed earnings per share of -70 cents, missing the estimate of -63 cents. With 246.11K shares outstanding, the current market capitalization sits at 1.48B.

View a ticker or compare two or three

Compare

NRIX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NRIX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NRIX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1700 Owens Street

Phone

+1 415 660-5320

Employees

284

Web

http://www.nurixtx.com